Risk for Sporadic Breast Cancer in Ataxia Telangiectasia Heterozygotes
Abstract
The scope of this IDEA grant is to assess whether heterozygosity for the ATM gene, due to a loss of function mutation in one of the 2 alleles and found in about 1% of the general population, confers a significant increase in breast cancer risk for women with sporadic breast cancer (without a family history of breast cancer). This is called the AT - carrier risk hypothesis for sporadic breast cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 1999
- Accession Number
- ADA389636
Entities
People
- Ute M. Moll
Organizations
- State University of New York